FindTrial
Sign In

Study comparing the effects of 0.75% Ropivacaine heavy and 0.5% Bupivacaine heavy in intrathecal injections during elective procedures

A Comparative study of intrathecal 0.75% Ropivacaine heavy versus 0.5% Bupivacaine heavy in elective surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056690
Enrollment
80
Registered
2023-08-21
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: intrathecal 0.75% Ropivacaine Heavy or 0.5% Bupivacaine Heavy: intrathecal administration of 0.75% Ropivacaine Heavy or 0.5% Bupivacine Heavy in elective surgeries Control Intervention1

Sponsors

Others
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: study will be done on eighty cases of either sex of ASA class-I or II between age group of 18-60 years weighing between 50-70kgs and height 160-170 cms scheduled for elective surgeries

Exclusion criteria

Exclusion criteria: Any h/o respiratory, cardiac, hepatic or renal disease, convulsions Patients with h/o bleeding disorder local infection at the site of injection H/o allergy to local anesthetic agent

Design outcomes

Primary

MeasureTime frame
Onset of sensory block Duration of sensory block onset of motor block duration of motor blockTimepoint: Baseline, 2 minutes, 4 minutes, 6 minutes, 8 minutes—

Secondary

MeasureTime frame
incidence of urinary retention, anaphylaxis, postoperative nausea and vomitingTimepoint: 06 hours, 12 hours, 24 hours—

Countries

India

Contacts

Public ContactDr Mukesh Kumar

Punjab Institute of Medical Sciences, Jalandhar

drmgrover@gmail.com8192951947

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026